These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37940199)

  • 21. Antifungal prophylaxis of COVID-19 associated pulmonary aspergillosis in ventilated patients: one solution does not fit all.
    Prattes J; Giacobbe DR; Bassetti M; Gangneux JP; Hoenigl M;
    Intensive Care Med; 2024 Aug; 50(8):1375-1377. PubMed ID: 38980361
    [No Abstract]   [Full Text] [Related]  

  • 22. Invasive pulmonary aspergillosis and candidiasis in a critically ill patient with COVID-19.
    Benedetti MF; de Abreu MS; Cadena RC; Arias MC; Posse G; Capece P; Nusblat A; Cuestas ML
    J Mycol Med; 2022 May; 32(2):101251. PubMed ID: 35123158
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era.
    Hernández-Silva G; Corzo-León DE; Becerril-Vargas E; Peralta-Prado AB; Odalis RG; Morales-Villarreal F; Ríos-Ayala MA; Alonso TG; Agustín FD; Ramón AF; Hugo AV
    Mycoses; 2024 Jan; 67(1):e13693. PubMed ID: 38214372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspergillus detection in airways of ICU COVID-19 patients: To treat or not to treat?
    Bounhiol A; Pasquier G; Novara A; Bougnoux ME; Dannaoui E
    J Mycol Med; 2022 Aug; 32(3):101290. PubMed ID: 35569323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort.
    Versyck M; Zarrougui W; Lambiotte F; Elbeki N; Saint-Leger P
    J Mycol Med; 2021 Jun; 31(2):101122. PubMed ID: 33621792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis.
    de Brabander J; Boers LS; Kullberg RFJ; Duitman JW; Bos LDJ;
    Lancet Respir Med; 2022 Mar; 10(3):e25-e26. PubMed ID: 35122732
    [No Abstract]   [Full Text] [Related]  

  • 27. [Aspergillus-related respiratory conditions and COPD: Diagnostic challenges].
    Ehret N; Carlier N; Marey J; Rabbat A; Burgel PR; Roche N
    Rev Mal Respir; 2020 Apr; 37(4):308-319. PubMed ID: 32284206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis - Authors' reply.
    Gangneux JP; Morcet J; Laviolle B; Dannaoui E; Timsit JF; Ruckly S; Zahar JR; Bougnoux ME
    Lancet Respir Med; 2022 Mar; 10(3):e27. PubMed ID: 35122731
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19-associated pulmonary aspergillosis in ICU patients in a German reference centre: Phenotypic and molecular characterisation of Aspergillus fumigatus isolates.
    Kirchhoff L; Braun LM; Schmidt D; Dittmer S; Dedy J; Herbstreit F; Stauf R; Steckel NK; Buer J; Rath PM; Steinmann J; Verhasselt HL
    Mycoses; 2022 Apr; 65(4):458-465. PubMed ID: 35138651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What is new … in the treatment of invasive mycosis: COVID-19-associated pulmonary aspergillosis].
    Scharf C; Zoller M; Liebchen U
    Anaesthesist; 2021 May; 70(5):432-433. PubMed ID: 33635372
    [No Abstract]   [Full Text] [Related]  

  • 31. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
    Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
    Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The performance of real-time PCR, galactomannan, and fungal culture in the diagnosis of invasive aspergillosis in ventilated patients with chronic obstructive pulmonary disease (COPD).
    Aquino VR; Nagel F; Andreolla HF; de-Paris F; Xavier MO; Goldani LZ; Denning DW; Pasqualotto AC
    Mycopathologia; 2012 Aug; 174(2):163-9. PubMed ID: 22382738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proven Aspergillus flavus pulmonary aspergillosis in a COVID-19 patient: A case report and review of the literature.
    Salehi M; Khajavirad N; Seifi A; Salahshour F; Jahanbin B; Kazemizadeh H; Hashemi SJ; Dehghan Manshadi SA; Kord M; Verweij PE; Khodavaisy S
    Mycoses; 2021 Aug; 64(8):809-816. PubMed ID: 33576014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease.
    Razazi K; Arrestier R; Haudebourg AF; Benelli B; Carteaux G; Decousser JW; Fourati S; Woerther PL; Schlemmer F; Charles-Nelson A; Botterel F; de Prost N; Mekontso Dessap A
    Crit Care; 2020 Dec; 24(1):699. PubMed ID: 33339526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a
    Giacobbe DR; Prattes J; Wauters J; Dettori S; Signori A; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Klimko N; Shadrivova O; Cornely OA; Rautemaa-Richardson R; Koehler P; Lagrou K; Bassetti M; Hoenigl M;
    J Clin Microbiol; 2022 Apr; 60(4):e0229821. PubMed ID: 35321555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive pulmonary aspergillosis due to a mixed infection caused by Aspergillus flavus and Aspergillus fumigatus.
    Orzechowski Xavier M; Pasqualotto AC; Uchoa Sales Mda P; Bittencourt Severo C; Peixoto Camargo JJ; Severo LC
    Rev Iberoam Micol; 2008 Sep; 25(3):176-8. PubMed ID: 18785789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
    Erami M; Hashemi SJ; Raiesi O; Fattahi M; Getso MI; Momen-Heravi M; Daie Ghazvini R; Khodavaisy S; Parviz S; Mehri N; Babaei M
    Infection; 2023 Feb; 51(1):223-230. PubMed ID: 36107379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
    Denning DW; Cadranel J; Beigelman-Aubry C; Ader F; Chakrabarti A; Blot S; Ullmann AJ; Dimopoulos G; Lange C;
    Eur Respir J; 2016 Jan; 47(1):45-68. PubMed ID: 26699723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
    Kim SH; Hong JY; Bae S; Lee H; Wi YM; Ko JH; Kim B; Joo EJ; Seok H; Shi HJ; Yoo JR; Hyun M; Kim HA; Jang S; Mun SJ; Kim J; Kim MC; Jung DS; Kim SH; Peck KR
    J Korean Med Sci; 2022 May; 37(18):e134. PubMed ID: 35535369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
    Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.